Optellum welcomes one of world’s most visionary and influential thought leaders in lung cancer screening, Dr. Matthijs Oudkerk, to join its Medical Advisory Board.

Matthijs Oudkerk is the Professor and Chair of Radiology at the University Medical Center Groningen.   He is the co-Principal Investigator of the NELSON study (Europe’s largest lung cancer screening trial) and the lead author of the official EU position statement, on how lung cancer screening shall be implemented in Europe (Lancet Oncology, November 2017)

Prof. Oudkerk joins a team of global leading lung cancer experts that help Optellum redefine early interception of lung cancer, including

• Fergus Gleeson MD, Professor of Radiology,  University of Oxford  (co-author of British Thoracic Society pulmonary nodule & NICE lung cancer guidelines)
• Pierre Massion MD,  Pulmonologist, Cornelius Vanderbilt Chair in Medicine, Ingram Professor of Cancer Research, Vanderbilt Medical Center (a world-leading specialist in lung cancer biomarkers)
• Reginald Munden MD, Chair of Radiology,  Wake Forrest Baptist Health (former M.D. Anderson Cancer Centre PI in the National Lung Screening Trial)